Immediate-release: Initiate at lower dosage in frail elderly; 2.5 mg PO q8-12hr initially; may be increased to 5 mg q8-12hr if warranted. Extended-release: 5-10 mg PO qDay; pharmacokinetics similar to adults in elderly up to age 78 yr. Next: Interactions. Interaction Checker. Enter a drug name and oxybutynin. No Results. No Interactions Found. Interactions Found. Contraindicated. Serious. Figure 2: Mean steady state (± SD) R-oxybutynin plasma concentrations following administration of 5 to 20 mg oxybutynin chloride extended-release tablets once daily in children aged 5–15. Plot represents all available data normalized to an equivalent of oxybutynin chloride extended-release tablets 5 mg once daily. oxybutynin; tolterodine; darifenacin; These are usually taken as a tablet that you swallow, 2 or 3 times a day, although oxybutynin also comes as a patch that you place on your skin twice a week. You will usually start taking a low dose to minimise any possible side effects. The dose can be increased until the medicine is effective. Possible side effects of antimuscarinics include: dry mouth. Oxybutynin oral tablets are used to treat overactive bladder. The immediate-release oral tablet is available in a generic version only. The extended-release oral tablet is available as a generic. Oxybutynin, sold as under the brand names Ditropan among others, is a medication used to treat overactive bladder. It works similar to tolterodine, Darifenacin, and Solifenacin. While used for bed wetting in children, evidence to support this use is poor. It is taken by mouth or applied to the skin. Common side effects include dry mouth, dizziness, constipation, trouble sleeping, and urinary. 2 Hughes KM et al. Measurement of Oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers. Xenobiotica. 1992; 22 (7): 859–869. 3 Ouslander J et al. Pharmacokinetics and Clinical Effects of Oxybutynin in Geriatric Patients. J. Urol. 1988; 140: 47–50. decline in MMSE score of 0.33 points over 2 years has been suggested. 4 • Additionally, each one point increase in the ACB total score has been correlated with a 26% increase in the risk of death. 4 Aging Brain Care Frequency of adverse reactions is based on safety data from clinical studies with oxybutynin hydrochloride 2.5 mg and 5 mg, and the experience gained after the drug has been marketed. Responses have been ranked under headings of body systems and their frequencies as follows, where possible: very common (≥ 1 / 10), common (≥ 1 / 100 and 1 / 10), uncommon (≥ 1 /1000 and 1 / 100), rare. Oxybutynin relaxes the muscles of the bladder. This will mean that the bladder can hold more urine (wee) and will help your child to control their bladder so that they do not wet themselves. What is oxybutynin available as? Tablets: 2.5 mg, 2.5 mg, 3 mg, 5 mg; these contain a small amount of lactose.